Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : SIL-204
Therapeutic Area : Oncology
Study Phase : Preclinical
Recipient : Silexion Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration
Silexion Therapeutics collaborates with Evonik on advanced siRNA Formulation Development
Details : Through the collaboration, Evonik’s proprietary biodegradable long-acting PLGA microparticle formulation will used for SIL-204, Silexion’s siRNA candidate for KRAS mutated Pancreatic cancer.
Product Name : Undisclosed
Product Type : Large molecule
Upfront Cash : Undisclosed
December 17, 2024
Lead Product(s) : SIL-204
Therapeutic Area : Oncology
Highest Development Status : Preclinical
Recipient : Silexion Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration
Lead Product(s) : Cellulose
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Approved
Sponsor : JeNaCell
Deal Size : Not Applicable
Deal Type : Not Applicable
Evonik Company JenaCell Launches Wound Dressing Epicite® Balance for Chronic Wounds
Details : epicite® balance is made of biosynthetic cellulose, a hydropolymer for innovative medical device applications. The dressing enables superior wound cleansing effects and reactivates the healing of slow-healing wounds.
Product Name : Epicite® Balance
Product Type : Large molecule
Upfront Cash : Not Applicable
July 14, 2023
Lead Product(s) : Cellulose
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Approved
Sponsor : JeNaCell
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Cellulose
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Approved
Sponsor : JeNaCell
Deal Size : Not Applicable
Deal Type : Not Applicable
Evonik Company JeNaCell Launches Wound Dressing Epicite® Balance for Chronic Wounds
Details : epicite® balance is made of biosynthetic cellulose, a hydropolymer for innovative medical device applications. The dressing enables superior wound cleansing effects and reactivates the healing of slow-healing wounds.
Product Name : Epicite® Balance
Product Type : Large molecule
Upfront Cash : Not Applicable
June 13, 2023
Lead Product(s) : Cellulose
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Approved
Sponsor : JeNaCell
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Bupivacaine
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : Allay Therapeutics
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : ATX-101 is a small product placed directly into the TKA surgical site in a simple, ‘place & go’ manner designed to add minimal extra complexity and time to the procedure.
Product Name : ATX-101
Product Type : Small molecule
Upfront Cash : Not Applicable
December 13, 2022
Lead Product(s) : Bupivacaine
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : Allay Therapeutics
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Vonoprazan Fumarate,Amoxicillin Trihydrate,Clarithromycin
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved
Sponsor : Phathom Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Agreement
Evonik and Phathom Pharmaceuticals Partner to Produce Novel Acid-Blocker Vonoprazan
Details : Vonoprazan is a novel potassium-competitive acid blocker (PCAB). It inhibits gastric acid secretion by acting as a reversible competitive inhibitor against potassium ions.
Product Name : Voquezna Triple Pack
Product Type : Small molecule
Upfront Cash : Undisclosed
October 24, 2022
Lead Product(s) : Vonoprazan Fumarate,Amoxicillin Trihydrate,Clarithromycin
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Sponsor : Phathom Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Agreement
Lead Product(s) : mRNA-based Therapy
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : BARDA
Deal Size : $220.0 million
Deal Type : Funding
Details : Lipids, molecules that make up the building blocks of living cells, are critical to producing mRNA-based drugs. The mRNA is enclosed in a lipid nanoparticle (LNP) composed of specific lipids. The LNP protects the mRNA and delivers it safely into the cell...
Product Name : Undisclosed
Product Type : Large molecule
Upfront Cash : Undisclosed